Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).

[1]  Jenny C. Chang,et al.  Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast , 2014, British Journal of Cancer.

[2]  S. Barni,et al.  The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis , 2014, Breast Cancer Research and Treatment.

[3]  A. Ashworth,et al.  Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast , 2014, The Journal of pathology.

[4]  Sang‐wook Lee,et al.  Treatment results of breast cancer patients with locoregional recurrence after mastectomy , 2013, Radiation oncology journal.

[5]  K. Shin,et al.  Prophylactic Supraclavicular Radiotherapy after Surgery in High-Risk N1 Breast Cancer , 2013, Oncology.

[6]  Jenny C. Chang,et al.  Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis. , 2013, Clinical breast cancer.

[7]  M. Kerin,et al.  Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype , 2012, Breast Cancer Research and Treatment.

[8]  R. Gelber,et al.  Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  E. Cho,et al.  Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study. , 2010, Breast.

[10]  S. Ahn,et al.  Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component. , 2009, Archives of pathology & laboratory medicine.

[11]  Paul J. L. Zhang,et al.  The Presence of Micropapillary Features and Retraction Artifact in Core Needle Biopsy Material Predicts Lymph Node Metastasis in Breast Carcinoma , 2009, The American journal of surgical pathology.

[12]  Xin-min Zhang,et al.  Breast Carcinoma With Micropapillary Features: Clinicopathologic Study and Long-Term Follow-Up of 100 Cases , 2008, International journal of surgical pathology.

[13]  C. Hurkmans,et al.  High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. , 2006, International journal of radiation oncology, biology, physics.

[14]  M. Gilcrease Immunohistochemical and Clinicopathologic Characteristics of Invasive Ductal Carcinoma of Breast With Micropapillary Carcinoma Component , 2006 .

[15]  C. Manivel,et al.  Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. , 2004, American journal of clinical pathology.

[16]  P. Glazer,et al.  Molecular markers in clinical radiation oncology , 2003, Oncogene.

[17]  B. Haffty Molecular and genetic markers in the local-regional management of breast cancer. , 2002, Seminars in radiation oncology.

[18]  B. Haffty,et al.  Local‐Regional Breast Cancer Recurrence: Prognostic Groups Based on Patterns of Failure , 2002, The breast journal.

[19]  I. Bleiweiss,et al.  Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. , 2001, Human pathology.

[20]  A. Thor,et al.  Invasive micropapillary carcinoma of the breast: A prognostic study☆ , 1999 .

[21]  M. Merino,et al.  Infiltrating micropapillary carcinoma of the breast. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[22]  F. Tavassoli,et al.  Invasive micropapillary carcinoma of the breast. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[23]  B. Fowble,et al.  A practical method of delivering the posterior axillary boost for the treatment of patients with breast cancer. , 1986, International journal of radiation oncology, biology, physics.

[24]  R. Selvi Invasive Micropapillary Carcinoma , 2015 .

[25]  B. Weill,et al.  Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54. , 2000, Pathology, research and practice.

[26]  A. Fernández-Cid,et al.  Invasive micropapillary carcinoma. Distinct features of a poorly recognized variant of breast carcinoma. , 1999, European journal of gynaecological oncology.

[27]  J. J. Bretón,et al.  Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas. , 1996, Pathology, research and practice.